Free regulatory intelligence — powered by Certivo
Public CommentProposedProposed RegulationNews

Illinois SB3507 postponed in committee; would expand PMP check/documentation expectations for Schedule II and IV prescriptions

Illinois Controlled Substances Act (720 ILCS 570)Illinois General AssemblyUS, Illinois
Announced

Mar 4, 2026

Description

Illinois SB3507 (104th GA) saw committee activity on 2026-03-04 (postponed in Senate Licensed Activities). The proposal would amend Illinois Controlled Substances Act PMP-related requirements (referenced in research as 720 ILCS 570/314.5) to broaden documentation expectations around attempting to access Prescription Monitoring Program (PMP) patient information when prescribing Schedule II and IV controlled substances (with stated exceptions in the research text, e.g., certain oncology/palliative care or limited emergency department supplies). Compliance teams supporting prescribers and healthcare organizations should monitor because it could expand when PMP lookups and related documentation are required for controlled-substance prescribing workflows.

Get compliance alerts for Illinois Controlled Substances Act (720 ILCS 570)

Certivo tracks regulatory changes and automates compliance workflows for your products.

Start Free Trial